Addison's Disease Clinical Trial
Official title:
Effect of Hydrocortisone Stress Dose on Exercise Capacity and Post-exercise Recovery in Patients With Addison's Disease
Exposure to stress alters the activity of the adrenomedullary, adrenocortical and sympathetic nervous system, depending on the type and intensity of the stressor. Physical exercise represents a stress condition influencing many systems in the body. Given a workload of at least 70-85% of Vo2max, exercise is a potent stimulus of the hypothalamic-pituitary-adrenal (HPA)-axis. The increased endogenous cortisol secretion results in important metabolic and cardiovascular effects to maintain cellular and organ homeostasis. Patients with Addison's disease are not able to meet the increased demand of adrenal steroids in case of physical exercise, which may result in an impaired exercise capacity and a prolonged post-exercise recovery. We hypothesize that a hydrocortisone stress dose increases exercise capacity and improves post-exercise recovery in patients with Addison's disease.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00444119 -
Survey in Patients With Chronic Adrenal Insufficiency in Germany
|
N/A | |
Completed |
NCT01452893 -
Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type I
|
N/A | |
Recruiting |
NCT05350020 -
The Effects of Two Brands of Hydrocortisone Injected Intramuscularly Into Deltoid and Thigh Muscles
|
Phase 4 | |
Completed |
NCT01063569 -
Glucocorticoid Treatment in Addison's Disease
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04252001 -
Growing up With the Young Endocrine Support System (YESS!)
|
N/A | |
Completed |
NCT00688987 -
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
|
N/A | |
Completed |
NCT00004313 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency
|
Phase 3 |